Ticker Symbol: PHGE
BiomX Inc
$2.19 - 20-12-2024 4 p.m. ET
Exchange: NYSE MKT LLC
Currency:
USD
Asset
Type: Common Stock
CIK:0001739174
Company Profile
BiomX is a clinical-stage biotechnology company developing both natural and engineered phage cocktails designed to target and destroy bacteria that affect the appearance of skin, as well as target bacteria in the treatment of chronic diseases, such as inflammatory bowel disease, primary sclerosing cholangitis, cystic fibrosis, atopic dermatitis and colorectal cancer. BiomX discovers and validates proprietary bacterial targets and customizes phage compositions against these targets.
Sector: Manufacturing
Industry: Biological Product (except Diagnostic) Manufacturing
Standard Industrial Classification Code (SIC code): 2836
Address: N/A
Website: www.biomx.com
CEO: N/A
Tags:
- Health Technology
- Pharmaceuticals: Major
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $0.35
Change:
$0.00
(
-1.96%)
Days Range: $0.33 - $0.35
Beta: -
52wk. High: $0.69
52wk. Low: $0.13
Ytd. Change 89.25%
50 Day Moving Average: $0.35
200 Day Moving Average: $0.34
Shares Outstanding: 45979730
Valuation
Market Cap: 1.6B
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A